Sandra Weber, MD
Endocrinology, Diabetes & Metabolism · Greenville, SCNPI 1821039041
Payments from drug & device makers
Across 590 payments — averaging $317.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk AS$183K
- Novo Nordisk$519
- Insulet Corporation$481
- Medtronic$387
- Abbott$379
- AbbVie$320
- plus $3K from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk AS | 375 | $182,532 |
| Novo Nordisk | 29 | $519 |
| Insulet Corporation | 13 | $481 |
| Medtronic(2 entities) | 8 | $387 |
| Abbott | 17 | $379 |
| AbbVie(2 entities) | 8 | $320 |
| Lilly USA, LLC | 14 | $282 |
| Dexcom, Inc. | 31 | $269 |
| Boehringer Ingelheim | 7 | $221 |
| Corcept Therapeutics | 7 | $218 |
| Ascensia Diabetes Care US Inc. | 6 | $215 |
| Amgen(2 entities) | 8 | $199 |
| Xeris Pharmaceuticals, Inc. | 8 | $162 |
| Sanofi-aventis U.S. LLC | 8 | $143 |
| Mannkind Corporation | 5 | $123 |
| Amarin Pharma, Inc. | 7 | $105 |
| Tandem Diabetes Care, Inc. | 4 | $101 |
| Pfizer | 4 | $72 |
| Novartis | 3 | $69 |
| Madrigal Pharmaceuticals | 2 | $56 |
| Cequr Corporation | 3 | $53 |
| Intuity Medical Inc | 3 | $51 |
| Amneal Pharmaceuticals LLC | 3 | $51 |
| Chiesi USA, Inc. | 2 | $49 |
| Radius Health, Inc. | 2 | $49 |
| Embecta Corp. | 2 | $44 |
| BD | 2 | $35 |
| Lifescan, Inc. | 2 | $34 |
| Antares Pharma, Inc. | 2 | $33 |
| Sequel Med Tech, LLC | 1 | $22 |
| Shire North American Group Inc | 1 | $20 |
| Ipsen Biopharmaceuticals, Inc | 1 | $18 |
| Recordati_rare_diseases_inc. | 1 | $18 |
| Tolmar, Inc. | 1 | $15 |
How this compares
$187,342 in reported general payments places this provider in the 85th percentile of 99 endocrinology, diabetes & metabolism providers in South Carolina.
See all endocrinology, diabetes & metabolism providers in South Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology, diabetes & metabolism in Greenville
- Cory WhiteGreenville$413K
- James HortonGreenville$73K
- John BruchGreenville$25K
- Maximilien RappaportGreenville$17K
- Mojgan RahmaniyanGreenville$6K
- Ronald MayfieldSpartanburg$8.9M
- Donald EagertonMyrtle Beach$7.9M
- Beatrice HullCharleston$987K
- Anne LarochelleMyrtle Beach$678K
- Gauri DhirMyrtle Beach$417K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.